(D-Ser2, Leu5, Thr6)-Enkephalin
(D-Ser2, Leu5, Thr6)-Enkephalin is a synthetic analog of the naturally occurring enkephalins, which are endogenous opioid peptides that play a crucial role in modulating pain and emotion in the central nervous system. This particular analog is modified at the second, fifth, and sixth positions of the peptide chain, which alters its binding affinity and selectivity for opioid receptors.
Structure and Synthesis[edit]
(D-Ser2, Leu5, Thr6)-Enkephalin is a pentapeptide with the sequence Tyr-D-Ser-Gly-Phe-Leu-Thr. The modifications include the substitution of the second amino acid with D-serine, the fifth with leucine, and the sixth with threonine. These modifications are designed to enhance the peptide's stability and receptor selectivity.
The synthesis of this peptide involves solid-phase peptide synthesis (SPPS), a method commonly used for the production of peptides. The process begins with the attachment of the C-terminal amino acid to a solid resin, followed by sequential addition of protected amino acids. After the assembly of the peptide chain, the protecting groups are removed, and the peptide is cleaved from the resin.
Pharmacology[edit]
(D-Ser2, Leu5, Thr6)-Enkephalin primarily acts on the δ-opioid receptors, although it may also have some affinity for μ-opioid receptors. The modifications in its structure are intended to increase its selectivity for δ-opioid receptors, which are implicated in modulating mood and emotional responses, as well as providing analgesic effects.
Biological Effects[edit]
The biological effects of (D-Ser2, Leu5, Thr6)-Enkephalin include analgesia, modulation of emotional states, and potential neuroprotective effects. Its action on δ-opioid receptors can lead to reduced perception of pain and may influence mood regulation, making it a compound of interest in the study of depression and anxiety disorders.
Research and Applications[edit]
Research into (D-Ser2, Leu5, Thr6)-Enkephalin is ongoing, with studies focusing on its potential therapeutic applications in pain management and mood disorders. Its ability to selectively target δ-opioid receptors makes it a promising candidate for developing new analgesics with fewer side effects compared to traditional opioids.
Also see[edit]
